Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
15 pending office actions • 10 art units • 14 examiners • 0 of 15 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
Nautilus Subsidiary Inc. currently manages 15 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 14 distinct examiners and 10 distinct art units. This distribution indicates a broad spread of examination across the USPTO, with very little concentration in any single examiner's docket.
RAMADAN, OMAR is identified as the busiest examiner for this portfolio, currently handling 2 pending office actions. This represents a small portion of the total 15 pending office actions. The presence of 10 distinct art units suggests that the company's biotechnology and pharmaceutical innovations span multiple specialized classifications within the patent office.
Practitioners should note that with 14 distinct examiners for 15 actions, almost every pending matter is being reviewed by a different individual. This lack of examiner overlap means that prosecution strategies may need to be tailored to the specific preferences and tendencies of many different officials rather than focusing on a single primary contact. Managing 10 distinct art units requires a sophisticated understanding of various examination guidelines within the Biotechnology & Pharmaceuticals sector.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (20%) |
| §103 only | 2 (13%) |
| §112 only | 1 (7%) |
| Double-patenting + other | 3 (20%) |
| Multi-statute (no §101) | 6 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMADAN, OMAR | 2 | 25.8% | +56.3% |
| EOM, ROBERT J | 1 | 57.5% | +34.7% |
| GREENE, CAROLYN LEE | 1 | 65.3% | +47.3% |
| WRIGHT, PATRICIA KATHRYN | 1 | 65.3% | +42.6% |
| PHAM, KHAI QUYNH TIEN | 1 | 0.0% | +0.0% |
| COLE, HOUSTON DAVID | 1 | — | — |
| BOWERS, NATHAN ANDREW | 1 | 59.4% | +31.9% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.5% | +23.3% |
| HORLICK, KENNETH R | 1 | 78.9% | +15.3% |
| RIGGS II, LARRY D | 1 | 46.3% | +32.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18364200 | CHEMICAL MODIFICATION OF ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF | WHITE, DAWANNA SHAR-DAY | 22d |
| 17848169 | METHODS AND SYSTEMS FOR ASSAY REFINEMENT | SCHULTZHAUS, JANNA NICOLE | 34d |
| 18723016 | SYSTEMS AND METHODS FOR CARRYING OUT HIGHLY MULTIPLEXED BIOANALYSES | WRIGHT, PATRICIA KATHRYN | — |
| 18634901 | ARTIFICIAL PROTEINS FOR DISPLAYING EPITOPES | PHAM, KHAI QUYNH TIEN | — |
| 18438973 | AFFINITY REAGENTS HAVING ARTIFICIAL POLYMER SCAFFOLDS | RAMADAN, OMAR | — |
| 18533979 | CHARACTERIZATION OF GLYCANS AND GLYCOCONJUGATES | COLE, HOUSTON DAVID | — |
| 18188092 | METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTION | HORLICK, KENNETH R | — |
| 18045036 | HIGHLY MULTIPLEXABLE ANALYSIS OF PROTEINS AND PROTEOMES | RIGGS II, LARRY D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18813886 | COMPOSITIONS AND METHODS FOR DETECTING BINDING INTERACTIONS UNDER EQUILIBRIUM OR NON-EQUILIBRIUM CONDITIONS | GREENE, CAROLYN LEE | 24d overdue |
| 18364200 | CHEMICAL MODIFICATION OF ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF | WHITE, DAWANNA SHAR-DAY | 22d |
| 19257053 | DECODING APPROACHES FOR PROTEIN IDENTIFICATION | EOM, ROBERT J | — |
| 18723016 | SYSTEMS AND METHODS FOR CARRYING OUT HIGHLY MULTIPLEXED BIOANALYSES | WRIGHT, PATRICIA KATHRYN | — |
| 18438973 | AFFINITY REAGENTS HAVING ARTIFICIAL POLYMER SCAFFOLDS | RAMADAN, OMAR | — |
| 18546410 | STRUCTURE AND METHODS FOR DETECTION OF SAMPLE ANALYTES | BOWERS, NATHAN ANDREW | — |
| 18188092 | METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTION | HORLICK, KENNETH R | — |
| 18045036 | HIGHLY MULTIPLEXABLE ANALYSIS OF PROTEINS AND PROTEOMES | RIGGS II, LARRY D | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| 1681 | 1 |
| 1799 | 1 |
| 1627 | 1 |
| 1686 | 1 |
| 1684 | 1 |
| 1685 | 1 |
| 1678 | 1 |
| 1677 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19257053 | DECODING APPROACHES FOR PROTEIN IDENTIFICATION | EOM, ROBERT J | 1797 | §102§103DP | Non-Final OA | — | Pending | Jul 01, 2025 |
| 18813886 | COMPOSITIONS AND METHODS FOR DETECTING BINDING INTERACTIONS UNDER EQUILIBRIUM OR NON-EQUILIBRIUM CONDITIONS | GREENE, CAROLYN LEE | 1681 | §112 | Non-Final OA | 24d overdue | Pending | Aug 23, 2024 |
| 18723016 | SYSTEMS AND METHODS FOR CARRYING OUT HIGHLY MULTIPLEXED BIOANALYSES | WRIGHT, PATRICIA KATHRYN | — | §102§103§112 | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18634901 | ARTIFICIAL PROTEINS FOR DISPLAYING EPITOPES | PHAM, KHAI QUYNH TIEN | — | §103§112 | Non-Final OA | — | Pending | Apr 13, 2024 |
| 18438973 | AFFINITY REAGENTS HAVING ARTIFICIAL POLYMER SCAFFOLDS | RAMADAN, OMAR | — | §102§103 | Non-Final OA | — | Pending | Feb 12, 2024 |
| 18533979 | CHARACTERIZATION OF GLYCANS AND GLYCOCONJUGATES | COLE, HOUSTON DAVID | — | §101§103§112 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18546410 | STRUCTURE AND METHODS FOR DETECTION OF SAMPLE ANALYTES | BOWERS, NATHAN ANDREW | 1799 | §103DP | Final Rejection | — | Pending | Aug 14, 2023 |
| 18364200 | CHEMICAL MODIFICATION OF ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF | WHITE, DAWANNA SHAR-DAY | 1627 | §102§103 | Non-Final OA | 22d | Pending | Aug 02, 2023 |
| 18188092 | METHODS AND SYSTEMS FOR INTEGRATED ON-CHIP SINGLE-MOLECULE DETECTION | HORLICK, KENNETH R | — | §102§103§112Other | Non-Final OA | — | Pending | Mar 22, 2023 |
| 18045036 | HIGHLY MULTIPLEXABLE ANALYSIS OF PROTEINS AND PROTEOMES | RIGGS II, LARRY D | 1686 | §101§102§103§112 | Non-Final OA | — | Pending | Oct 07, 2022 |
| 17933051 | METHODS OF ASSAYING PROTEINS | FLINDERS, JEREMY C | 1684 | §102DP | Non-Final OA | — | Pending | Sep 16, 2022 |
| 17848169 | METHODS AND SYSTEMS FOR ASSAY REFINEMENT | SCHULTZHAUS, JANNA NICOLE | 1685 | §101§102§103§112 | Final Rejection | 34d | Pending | Jun 23, 2022 |
| 17825867 | SOLUTION PHASE SINGLE MOLECULE CAPTURE AND ASSOCIATED TECHNIQUES | RAMADAN, OMAR | 1678 | §102§103 | Final Rejection | — | Pending | May 26, 2022 |
| 17677255 | STRUCTURE AND METHODS FOR DETECTION OF SAMPLE ANALYTES | EVANS, CHRISTOPHER RYAN | 1677 | §103Other | Final Rejection | 14d | Pending | Feb 22, 2022 |
| 17537004 | SUBSTRATE FOR SINGLE MOLECULE ORGANIZATION | SIMMONS, VALERIE MICHELLE | 1758 | §103 | Non-Final OA | — | Pending | Nov 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial